Hu-Hu Zeng

机构：Jinan University, Guangdong Pharmaceutical University, Laboratoire de Chémo-biologie synthétique et thérapeutique

发表论文 11 篇 · 总被引 164 次 · h-index 6

代表论文

• ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy (2023 · Nature Metabolism · 被引 49)
• The FAP -activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway (2021 · Acta Pharmaceutica Sinica B · 被引 37)
• Holistic quality evaluation of Qingwen Baidu Decoction and its anti-inflammatory effects (2020 · Journal of Ethnopharmacology · 被引 25)
• Overall quality control of the chemical and bioactive consistency of ShengMai Formula (2020 · Journal of Pharmaceutical and Biomedical Analysis · 被引 20)
• Pericyte drives the formation of circulating tumour cell-neutrophil clusters to promote colorectal cancer metastasis (2025 · Gut · 被引 12)
• Myrcaulones A–C, Unusual Rearranged Triketone–Terpene Adducts from Myrciaria cauliflora (2020 · Journal of Natural Products · 被引 12)